Stent made in innovative technology allowing to use the sirolimus drug on both the surface of the stent and the balloon.
Only the outer surface of the stent has the drug and the release occurs only intramurally (40-45 days), which makes it better and faster to endothelize the inner surface of the stent.
Both, stent and exposed parts of the balloon are covered with Sirolimus – upon inflation the thin and elastic film is created, which covers whole surface of stented vessel segment, offering short-term drug release from the balloon and longer term drug release from stent struts. This feature is especially beneficial in diabetic patients, with diffuse lesions
• Immediate release of the drug from the balloon
• Programmed release of the drug from stent